Abstract
Recently, several cases of melioidosis imported to Europe have been reported. The diagnosis of the acute or chronic infection remains challenging. This report describes an optimised protocol for fast and reliable DNA preparation for use in two different polymerase chain reaction (PCR) assays, namely: (1) a seminested PCR assay targeting a genus specific sequence of the ribosomal protein subunit 21 (rpsU) gene and (2) a nested PCR assay targeting the gene encoding the filament forming flagellin (fliC). Various strains of Burkholderia spp, strains of closely related genera, and spleen tissue samples of experimentally infected mice were investigated. The combination of PCR and sequencing of the amplicons resulted in high sensitivity and specificity. These procedures may allow rapid, sensitive, and reliable detection of B pseudomallei DNA in routinely formalin fixed and paraffin wax embedded samples, thus providing a safe diagnostic tool and avoiding the cultivation of a risk group 3 agent. In addition, this method could be useful for retrospective histopathological investigations.
Keywords: Burkholderia pseudomallei, melioidosis, polymerase chain reaction, pathology
Melioidosis, a potentially fatal infection in humans and animals, is caused by Burkholderia pseudomallei, a motile, non-spore forming, Gram negative bacterium.1 This saprophyte is found in surface water and the soil of endemic areas in tropical and subtropical regions between latitudes 20° north and 20° south. Melioidosis should also be suspected in travellers or refugees from endemic areas presenting with an acute febrile disease or symptoms of a chronic ulcerative or abscess forming infection.2,3 Because of the rapidly growing number of newly described and phylogenetically related species, it is difficult to identify B pseudomallei. Consequently, melioidosis causes diagnostic problems in endemic and even more in non-endemic areas when imported.3–6
During the past decade, many efforts have been made to develop new molecular procedures to identify B pseudomallei from different specimens. Most polymerase chain reaction (PCR) approaches were sensitive, detecting as few as one bacterium/ml, but showed a lack of specificity. In subacute and chronic forms, when blood culture and PCR from blood samples are often negative, biopsy may be required, but histological findings are not specific.2 The detection of B pseudomallei from tissue by means of PCR has not been described so far.
“Most polymerase chain reaction approaches were sensitive, detecting as few as one bacterium/ml, but showed a lack of specificity”
The quality of the template DNA depends on the sampling and purification procedures. Conventional protocols for dewaxing, digestion, and purification of DNA from paraffin wax embedded tissues are time consuming and may cause considerable loss of DNA.7 Therefore, we developed strategies for rapid and reliable DNA preparation from tissue samples, conserving the bacterial DNA, and thus allowing the amplification of specific sequences of either (1) the ribosomal protein subunit 21 (rpsU) gene or (2) the gene encoding the filament forming flagellin (fliC).
MATERIAL AND METHODS
BACTERIA
Bacterial strains (table 1 ▶) were cultured on nutrition agar, swabbed from the plates with sterile 0.9% NaCl solution, adjusted to 108 to 109 bacteria/ml, and heat inactivated.
Table 1.
Species | Source | rpsU PCR | fliC PCR |
Burkholderia pseudomallei | ATCC 15682 | 179 bp | 302 bp |
B pseudomallei | ATCC 23343 | 179 bp | 302 bp |
B pseudomallei | 6068VIR | 179 bp | 302 bp |
B thailandensis | ATCC 700388 | 179 bp | 302 bp |
B. mallei | ATCC 23344 | 179 bp | 302 bp |
B cepacia | ATCC 25416T | 179 bp | – |
B vietnamiensis | LMG 10929 | 179 bp | – |
B gladioli | ATCC 10248 | 179 bp | – |
B plantarii | LMG 9035 | 179 bp | – |
B vandii | ATCC 51545 | 179 bp | – |
Pseudomonas aeruginosa | DSM 1253 | – | – |
Ps fluorescens | IMB P162 human isolate | – | – |
Ps stutzeri | NCTC 10450 | – | – |
Escherichia coli | DSM 301 | – | – |
Francisella tularensis | ATCC 29684 | – | – |
Stenotrophomonas maltophilia | IMB P26 human isolate | – | – |
Staphylococcus aureus | DSM 346 | – | – |
Staphylococcus epidermidis | DSM 1798 | – | – |
Spleen mouse 1 (2.09 × 106)* | 179 bp | 302 bp | |
Spleen mouse 2 (2.21 × 107)* | 179 bp | 302 bp | |
Spleen mouse 3 (69)* | 179 bp | – | |
Spleen mouse 4 (1.46 × 108)* | 179 bp | 302 bp | |
Spleen mouse 5 (1.57 × 109)* | 179 bp | 302 bp | |
Spleen mouse 6 (2.64 × 108)* | 179 bp | 302 bp | |
Spleen mouse 7 (8.18 × 108)* | 179 bp | 302 bp | |
Spleen control mouse | 179 bp | – |
ATCC, American Type Culture Collection, Atlanta, USA; DSMZ, Deutsche Sammlung von Mikroorganismen, Braunschweig, Germany; IMB, Type collection Institut für Mikrobiologie, Munich, Germany; LMG, Laboratorium Microbiologie Gent Culture Collection, Belgium.
*Colony forming units/g of organ.
Experimental infection and organ samples
A mouse model for experimental melioidosis has been established and described recently.8 Spleen samples of SWISS mice infected with strain B pseudomallei 6068VIR were collected, and routinely formalin fixed and paraffin wax embedded at days 2, 3, 4, 5, and 7 after infection, from surviving animals only. A non-infected mouse served as the negative control. The bacterial load of the organs was determined by plating out on plate count agar (Merck, Darmstadt, Germany) and expressed as colony forming units (CFU)/g of organ. To determine the in vitro detection limit of the PCR, a bacterial suspension of B pseudomallei 6068VIR containing 5 × 108 CFU/ml was serially diluted one in five and inactivated, as described previously.8
DNA preparation
The bacterial suspensions were prepared according to the following protocol. For bacterial lysis, buffer contained 0.5% TweenTM 20 (ICI, American Limited, Merck, Hohenbrunn, Germany), 2 mg/ml proteinase K (Roche, Mannheim, Germany), 3.5mM MgCl2, 15mM ammonium sulfate, and 60mM Tris/HCl (pH 8.5). Aliquots (10 μl) of the heat inactivated bacterial suspensions were resuspended in 200 μl of lysis buffer, incubated at 56°C for two hours to obtain a clear lysate, and boiled for 10 minutes.
Sections (5 μm thick) were cut from paraffin wax blocks to give 1 mg of tissue and dewaxed by xylene extraction. The samples were incubated for 10 minutes in xylene at room temperature (1200 μl, 2×) and 100% ethanol (1200 μl, 3×) while gently agitating the tube. After subsequent centrifugation at 13 000 ×g for 10 minutes the supernatant was removed and the samples were then air dried. For digestion of the tissues, 200 μl of lysis buffer was added. The samples were then incubated for one hour at 56°C and mixed continuously. A clear lysate was obtained and the reaction was stopped by boiling the sample for 10 minutes. No further DNA extraction was performed.
DNA amplification procedures
A 1 μl aliquot of the cleared bacterial lysate or of the tissue sample lysate was used as template for both PCR assays. PCR primers (table 2 ▶) were designed based on the previously published sequence of the rpsU and fliC genes of B pseudomallei strain E503 (NCBI accession number, AF030239). The PCR mixture contained 0.5 U Taq polymerase (Perkin Elmer, Weiterstadt, Germany), 1μM of primers, 1mM dNTP, 2.5mM MgCl2 (rpsU PCR) or 1.75 mM (fliC PCR), 7.5mM ammonium sulfate, and 30mM Tris/HCl (pH 8.5). The rpsU PCR using the fup-1/fup-2 primers was performed under the following conditions: an initial denaturation step of 10 minutes at 94°C was followed by 35 cycles of denaturation for 60 seconds at 94°C, annealing for 60 seconds at 59°C, and elongation at 72°C for 60 seconds. An additional elongation step was performed for 10 minutes at 72°C. Further amplification of 0.5 μl aliquots was performed by seminested PCR using the rpsU-L2/fup-2 primers and applying the same conditions as the initial amplification except that annealing was carried out at 53°C. An already developed B mallei/B pseudomallei/B thailandensis specific filament forming flagellin (fliC) PCR assay based on primers fliC-1/fliC-29 was connected with a nested (inner) PCR assay using primers fliC-3/fliC-4. The fliC PCR was carried out as described previously.9
Table 2.
Primer | Sequence |
fup-1 | 5′-GTG GAG CTT CTT CGG CAG CAT-3′ |
fup-2 | 5′-ATG ACG ACG ATT CTT TTG AA-3′ |
rpsU-L2 | 5′-AGG CGC TTG TGC AGG CGC-3′ |
fliC-1 | 5′-GAT CGG CGG CGG CAT GGT TCA GA-3′ |
fliC-2 | 5′-CCG AGC GTT GCC TGC AGA TTG TT-3′ |
fliC-3 | 5′-GCA GCA CCG GCC AGG AGA CGA C-3′ |
fliC-4 | 5′-GCC CGT CTG CGT GCT GAT GTC-3′ |
In every PCR a negative control (without DNA) and positive controls (DNA preparation of B pseudomallei 6068VIR and B pseudomallei ATCC 15682) were included. An 8 μl aliquot of the PCR mix was analysed by agarose gel electrophoresis and ethidium bromide staining.
Sequencing
Direct sequencing of PCR products was done on ABI 377 PRISMTM dye sequencing apparatus using the ABI PRISM dye terminator cycle sequencing ready reaction kitTM, according to the manufacturer’s instructions (Perkin Elmer Applied Biosystems, Weiterstadt, Germany). Alignment studies were done using CLUSTAL 5.0.
RESULTS
The bacterial load of the spleens expressed as CFU/g of organ ranged from 69 to 1.57 × 109 bacteria/g (table 1 ▶). No cultivatable bacteria were found in the spleen from the control mouse. The seminested rpsU PCR assay allowed the detection of one bacterium/ml using diluted bacterial suspensions and gave positive results with amplicons of 179 bp length for all (burkholderia) reference strains, but not for the other bacterial species tested (table 2 ▶). Positive results were obtained from the tissues of all the mice. The PCR products were analysed by direct sequencing. Only the DNA sequences of three B pseudomallei reference strains and one B mallei reference strain were available from NCBI GenBank. The sequencing results of the partly sequenced rpsU gene from seven other (burkholderia) reference strains were submitted to NCBI GenBank with the following accession numbers: AF447444, AF447445, AF447446, AF447447, AF447448, AF447449, and AF447450. The PCR products from mice numbers 1, 2, 4, 5, 6, and 7 showed the same sequence as strain B pseudomallei 6068VIR. In contrast, the sequence of the PCR product from mouse number 3 was homologous to the sequence of reference strain B plantarii LMG 9035, the PCR product obtained from the control mouse showing the same sequence as the reference strain B vandii ATCC 51545. Therefore, these PCR products were identified as contaminants.
Take home messages.
This report describes an optimised protocol for fast and reliable DNA preparation for use in two polymerase chain reaction (PCR) assays targeting a genus specific sequence of the ribosomal protein subunit 21 (rpsU) gene and the gene encoding the filament forming flagellin (fliC)
The combination of two PCRs and sequencing of the amplicons resulted in high sensitivity and specificity
These procedures may allow rapid, sensitive, and reliable detection of B pseudomallei DNA in routinely formalin fixed and paraffin wax embedded samples, thus providing a safe diagnostic tool and avoiding the cultivation of a risk group 3 agent
The nested fliC PCR assay gave rise to amplicons of 302 bp in length for the B pseudomallei, B thailandensis, and B mallei reference strains, but not for members of other (burkholderia) species or the other genera (table 1 ▶). The nested fliC PCR gave positive results for the spleens from mice numbers 1, 2, 4, 5, 6, and 7, but not for the spleens from mouse number 3 and the control mouse. The identity of the amplicons was confirmed by direct sequencing of the PCR products. The sequences of all PCR products obtained originated from B pseudomallei DNA.
DISCUSSION
Here, we describe the development of a seminested PCR assay based on the sequences of the ribosomal protein subunit 21 (rpsU) gene10 and of a nested PCR assay targeting the gene encoding the filament forming flagellin (fliC) for the identification of B pseudomallei. We showed that both genes are highly conserved in the species B pseudomallei. Both PCR assays have been used successfully for the detection of bacterial DNA in formalin fixed, paraffin wax embedded spleen tissue from infected mice. The preparation of the specimens with a simple, rapid, and cheap method (lysis using proteinase K) gave reliable results.
“The high sensitivity and specificity recommend the use of this strategy for the diagnosis of melioidosis for retrospective histopathological studies”
We conclude that the combination of the two PCR assays with subsequent sequencing of the PCR products leads to a safe species specific identification of B pseudomallei, thereby avoiding the cultivation of this risk group 3 agent. The high sensitivity and specificity recommend the use of this strategy for the diagnosis of melioidosis for retrospective histopathological studies.
Acknowledgments
We thank C Lodri and H Grosser for expert technical assistance.
Abbreviations
CFU, colony forming units
PCR, polymerase chain reaction
REFERENCES
- 1.Yabuuchi E, Kosako Y, Oyaizu H, et al. Proposal of Burkholderia gen. nov. and transfer of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. Nov. Microbiol Immunol 1992;36:1251–75. [DOI] [PubMed] [Google Scholar]
- 2.Dharakul T, Songsivilai S. The many facets of melioidosis. Trends Microbiol 1999;4:138–40. [DOI] [PubMed] [Google Scholar]
- 3.Zysk G, Splettstösser WD, Neubauer H. A review on melioidosis with special respect on molecular and immunological diagnostic techniques. Clin Lab 2000;46:119–30. [PubMed] [Google Scholar]
- 4.Dance DAB, Wuthiekanun V, Naigowit P, et al. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J Clin Pathol 1989;42:645–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dance DAB, Smith MD, Aucken HM, et al. Imported melioidosis in England and Wales. Lancet 1999;353:208. [DOI] [PubMed] [Google Scholar]
- 6.Inglis TJJ, Chiang D, Lee GSH, et al. Potential misidentification of Burkholderia pseudomallei by Api 20NE. Pathology 1998;30:62–4. [DOI] [PubMed] [Google Scholar]
- 7.Rogers BB, Alpert LC, Hine EAS, et al. Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol 1990;136:541–8. [PMC free article] [PubMed] [Google Scholar]
- 8.Gauthier YP, Hagen RM, Brochier GS, et al. Study on the pathophysiology of experimental Burkholderia pseudomallei infection in mice. FEMS Immunol Med Microbiol 2001;30/1:53–63. [DOI] [PubMed] [Google Scholar]
- 9.Sprague LD, Zysk G, Hagen RM, et al. A possible pitfall in the identification of Burkholderia mallei using molecular identification systems based on the sequence of the flagellin c gene. FEMS Immunol Med Microbiol [In press.] [DOI] [PubMed]
- 10.DeShazer D, Brett PJ, Carlyon R, et al. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol 1997;179:2116–25. [DOI] [PMC free article] [PubMed] [Google Scholar]